PaperActivation of fibrinolysis by apolipoproteins of high density lipoproteins in man
References (15)
- et al.
Effects of dietary carbohydrate and fat on plasma lipoproteins and apo lipoproteins C-II and C-III in healthy men
J. Lipid Res.
(1982) - et al.
Protein measurement with the folin phenol reagent
J. Biol. Chem.
(1951) - et al.
A rapid and simple method for measurement of total protein in very low density lipoproteins by the Lowry assay
J. Lipid Res.
(1980) The effect of plasmin on human plasma low density lipoprotein
Thromb. Res.
(1979)- et al.
Degradation of the apoprotein A-I polypeptide chain of human high density lipoprotein by human plasmin
Thromb. Res.
(1981) - et al.
C-II anapolipoproteinemia and severe hypertriglyceridemia
Am. J. Med.
(1984) - et al.
The effect of lipoproteins on the synthesis of prostacyclin, Von Wellebrand factor and apolipoproteins A-I and A-II in cultured human endothelial cells
Atherosclerosis
(1984)
Cited by (117)
Degenerated HDL and Its Clinical Implications
2017, The HDL Handbook: Biological Functions and Clinical Implications: Third EditionExploring the impact of bariatric surgery on high density lipoprotein
2015, Surgery for Obesity and Related DiseasesOxidized High-Density Lipoprotein: Friend or Foe
2014, The HDL Handbook: Biological Functions and Clinical Implications: Second EditionAssociation of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: The atherosclerosis risk in communities study
2011, American Journal of the Medical SciencesCitation Excerpt :Although future trials will ultimately determine the benefit of cholesterol ester transport protein inhibitors, HDL-cholesterol has also been proposed to have other antiatherosclerosis properties. These include being an antioxidant, anti-inflammatory, nitric oxide promoter and platelet inhibitor.31–34 In Cox proportional hazards models including adjustment for LDL-cholesterol, each SD higher HDL-cholesterol (18 mg/dL) was associated with a 0.70 (95% CI: 0.63-0.77) risk of CHD.
High-density lipoproteins: Marker of cardiovascular risk and therapeutic target
2010, Journal of Clinical LipidologyCitation Excerpt :HDL can stimulate increased endothelial nitric oxide synthase and nitric oxide expression and induce vasodilation.65–67 HDL can also inhibit endothelial cell apoptosis68 and adhesion molecule expression,69 inhibit platelet activation and aggregation,70 can participate in immunity by carrying complement proteins,48 and stimulate urokinase dependent fibrinolysis71 and prostacyclin production by activating cyclooxygenase-2,72 among other functions. HDL carries a number of antioxidative enzymes (paraoxonase, platelet activating factor acetylhydrolase, glutathione peroxidase, and two redox active methionine centers in apoAI) that can facilitate the reduction and sequestration of oxidized lipid in LDL particles.73–77
Functional Change in the HDL Particle by Oxidative Modification and its Contribution to Atherogenesis
2010, The HDL Handbook: Biological Functions and Clinical Implications